FOR VETERINARY USE ONLY WITH A PRESCRIPTION

AVIQUONE is a veterinary anti-theileria medication (buparvaquone) to treat cattle

Composition

Each 1 ml AVIQUONE contains
Buparvaquone –50 mg

Properties

Buparvaquone is a second-generation hydroxynaphthoquinone related to parvaquone, with novel features that make it a promising compound for the therapy and prophylaxis

It has been tested extensively against Theileria annulata, T. Parva and T. sergenti, both in laboratory studies and in field trials, & it has undergone a rigorous programme of toxicology and safety studies

AVIQUONE is Formulated as a solution for intramuscular injection
Butalex, Coopers Animal Health, offers a safe and convenient alternative to existing antitheilerial product

Indications

AVIQUONE is an anti-theilerial treatment used in treating Bovine theileriosis
which is known also as East Coast fever, Corridor disease & Tropical theileriosis

In Ruminants caused by Theileria annulata, T. mutans, T. parva, and T. orientalis (sergenti

Its activity covers both the schizont and piroplasm phases of theileria could be also used in the incubation period of the disease, or in the clinical phase of the disease

Dosage

Only to be Injected by deep intramuscular injection

Cattle: 1 ml of per 20 kg . wt., (Equivalent to 2.5 mg buparvaquone per kg bw

In severe cases, another injection with the same dose is needed after 2-3 days of the first injection

Divide the dose so you do not administer more than 10 ml into each injection site

withdrawal period

Meat: 42 days
Milk: Should be discarded in the 48 hours following the last treatment

PRECAUTION

Local, oedematous swelling may be seen at the injection site

Buparvquone has some immune compromising effects, so avoid vaccinating animals during treatment

should never be given by intravenous or subcutaneous injection